New partnership with Excellerate Bioscience

Press release

Cisbio is announcing a new partnership for kinetic binding

Cisbio and Excellerate Bioscience partner on ligand kinetic binding services

The two companies unite their respective expertise in assay technology and pharmacology to provide researchers with a first-in-class assessment of compound kinetic binding based on Tag-lite®, Cisbio’s technology for receptor-ligand binding investigation.

Get the press release

Collaboration to deliver ligand kinetic binding assay services to the life science community

Under the terms of this agreement, Cisbio will market Excellerate Bioscience’s kinetic binding service offer throughout the European territory. Excellerate Bioscience will run the operations from its new facility in BioCity, Nottingham UK.

See the webpage
About Excellerate Bioscience

Based in BioCity Nottingham UK, Excellerate Bioscience applies state of the art pharmacological theory and technology to improve the efficiency and translatability of in vitro pharmacological profiling, providing solutions to some of world’s leading pharmaceutical, biotechnology and academic institutes.

See Excellerate website